We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $748M
1-Year Est. Return 27.21%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+27.21%
3 Year Est. Return
+69.53%
5 Year Est. Return
+110.76%
10 Year Est. Return
AUM
$702M
AUM Growth
+$37.4M
Cap. Flow
-$4.98M
Cap. Flow %
-0.71%
Top 10 Hldgs %
36.83%
Holding
74
New
2
Increased
31
Reduced
37
Closed

Top Buys

Rank Stock Value
1
A icon
Agilent Technologies
A
+$1.87M
2
MOH icon
Molina Healthcare
MOH
+$1.42M
3
DEO icon
Diageo
DEO
+$472K
4
CSCO icon
Cisco
CSCO
+$413K
5
SEIC icon
SEI Investments
SEIC
+$349K

Top Sells

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$3.79M
2
CPRT icon
Copart
CPRT
+$1.22M
3
NVO
Novo Nordisk
NVO
+$986K
4
AAPL icon
Apple
AAPL
+$695K
5
LLY icon
Eli Lilly
LLY
+$656K

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Industrials 19.09%
3 Financials 16.21%
4 Consumer Discretionary 14.72%
5 Healthcare 14.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$38.6M 5.5%
199,062
-3,987
-2% -$695K
MA icon
2
Mastercard
MA
$507B
$28.3M 4.03%
71,841
-128
-0.2% -$48K
MSFT icon
3
Microsoft
MSFT
$3.71T
$27M 3.84%
79,238
-1,070
-1% -$335K
AON icon
4
Aon
AON
$68.5B
$25.9M 3.7%
75,150
-211
-0.3% -$68.5K
CPRT icon
5
Copart
CPRT
$31.2B
$25.8M 3.68%
566,450
-29,510
-5% -$1.22M
ORCL icon
6
Oracle
ORCL
$457B
$25.7M 3.66%
215,618
-4,130
-2% -$427K
MKC icon
7
McCormick & Company Non-Voting
MKC
$14B
$23.2M 3.3%
265,805
-1,310
-0.5% -$116K
NVO
8
Novo Nordisk
NVO
$206B
$22.8M 3.25%
282,228
-12,070
-4% -$986K
GGG icon
9
Graco
GGG
$12.6B
$21.3M 3.03%
246,172
-5,772
-2% -$449K
APH icon
10
Amphenol
APH
$204B
$19.9M 2.84%
938,680
-6,848
-0.7% -$133K
TJX icon
11
TJX Companies
TJX
$145B
$19.6M 2.79%
230,685
-2,668
-1% -$210K
ACN icon
12
Accenture
ACN
$114B
$19M 2.7%
61,533
-469
-0.8% -$136K
UNH icon
13
UnitedHealth
UNH
$356B
$18.9M 2.7%
39,424
-532
-1% -$260K
TTC icon
14
Toro Company
TTC
$8.83B
$18.9M 2.69%
185,501
-2,226
-1% -$228K
SEIC icon
15
SEI Investments
SEIC
$13.2B
$18M 2.56%
301,516
+6,002
+2% +$349K
PEP icon
16
PepsiCo
PEP
$188B
$17.8M 2.54%
96,231
-1,295
-1% -$242K
ROL icon
17
Rollins
ROL
$17.3B
$17.2M 2.45%
401,627
-1,434
-0.4% -$58.3K
ORLY icon
18
O'Reilly Automotive
ORLY
$71.1B
$17M 2.43%
267,585
-3,900
-1% -$238K
AMGN icon
19
Amgen
AMGN
$236B
$16.5M 2.35%
74,155
+60
+0.1% +$13.9K
MRSH
20
Marsh
MRSH
$88.6B
$14.9M 2.12%
79,309
-1,550
-2% -$275K
NOC icon
21
Northrop Grumman
NOC
$73.2B
$14.7M 2.09%
32,159
-187
-0.6% -$84.8K
ROST icon
22
Ross Stores
ROST
$73.7B
$14M 2%
125,270
+242
+0.2% +$25.4K
EXPD icon
23
Expeditors International
EXPD
$24.5B
$14M 1.99%
115,609
-706
-0.6% -$80.3K
DLTR icon
24
Dollar Tree
DLTR
$24.7B
$13M 1.86%
79,026
+1,458
+2% +$215K
AME icon
25
Ametek
AME
$54.5B
$12.7M 1.8%
78,217
-10
-0% -$1.46K

Similar funds

JLB & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, JLB & Associates held 74 positions worth $702M, up 5.6% from $665M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 2.7%. JLB & Associates opened 2 new positions and made no exits, leaving the 74-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • JLB & Associates's largest Q2 2023 buy was Agilent Technologies: 14,714 shares worth $1.77M.
  • JLB & Associates added most to Diageo in Q2 2023, an estimated $472K increase.
  • JLB & Associates's biggest Q2 2023 reduction was Icon, cutting an estimated $3.79M.
  • JLB & Associates's ten largest holdings make up 37% of its $702M portfolio in Q2 2023.
  • JLB & Associates opened 2 new positions and closed 0 in Q2 2023.
  • JLB & Associates's portfolio value rose 5.6% quarter-over-quarter to $702M.

Based on JLB & Associates's 13F filing for Q2 2023, filed 20 Jul 2023.